Indication
Stage IVC Major Salivary Gland Carcinoma
2 clinical trials
4 products
Clinical trial
Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma of All Anatomic Sites of Origin and Non-adenoid Cystic Carcinoma Malignant Tumors of the Salivary GlandStatus: Active (not recruiting), Estimated PCD: 2021-02-24
Product
IpilimumabProduct
NivolumabClinical trial
A Single Arm Phase I/II Study of MK-3475 Combined With Vorinostat for Recurrent Unresectable and/or Metastatic Squamous Cell Head and Neck Cancer and Recurrent Unresectable and/or Metastatic Salivary Gland MalignanciesStatus: Completed, Estimated PCD: 2019-09-28
Product
PembrolizumabProduct
Vorinostat